Model N Lists IPO on the New York Stock Exchange – Celebrates First Day as a Publicly-Traded Company
NEW YORK, CA – March 20, 2013 – Redwood Shores, Calif.-based Model N, Inc., a leading revenue management solutions provider to the life science and technology industries, opened for trading today on the New York Stock Exchange (NYSE) under the ticker symbol “MODN” after its initial public offering. GETCO Securities LLC is the Designated Market Maker for the company’s stock.
Founder, Chairman and CEO Zack Rinat, accompanied by members of Model N’s leadership team, commemorated the company’s first day of trading by ringing the NYSE Opening BellSM and visiting the trading floor to witness the stock opening.
“Becoming a publicly traded company on the NYSE is recognition that Revenue Management software is a proven source of competitive advantage for companies in the life sciences and the technology industries. Furthermore it is a testament to our customers, partners, and employees daring to pioneer a new software category,” said Zack Rinat, Founder, Chairman, and CEO of Model N.
“We are delighted to welcome Model N to the NYSE’s growing community of technology companies,” said Scott R. Cutler, Executive Vice President, Head of Global Listings, NYSE Euronext. “Model N is a leader in revenue management solutions offering life science and technology companies around the globe a suite of innovative tools and services to support their distinctive business needs. We congratulate Model N on its first day as a publicly-traded company and look forward to sharing a long and fruitful partnership with Model N and its shareholders.”
For more information on NYSE Euronext’s listings business and to learn about trends in the IPO market, please visit the NYSE Euronext IPO Center.
About Model N
Model N is the leader in Revenue Management solutions. Model N helps its customers maximize their revenue and reduce revenue compliance risk by managing every dollar that impacts their top line encompassing contracting, pricing, incentives, and rebates. Model N leverages its deep industry expertise to support the unique business needs of Life Sciences and Technology companies in more than 50 countries. Global Customers include: Actavis, Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, and STMicroelectronics. Learn more at: www.modeln.com. Model N is traded on the New York Stock Exchange under the symbol MODN.
Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.